Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 4/20 | 0.76 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.52 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.52 |
| ▸ | CPB2 | Q96IY4 | 10/20 | 0.50 |
| ▸ | GNPAT | O15228 | 1/20 | 0.47 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12572609 | 0.91 | FOLH1 (0.83) | FOLH1RIMKLANAALAD2CPB2SLC6A5 | |
| SCHEMBL21235539 | 0.88 | FOLH1 (0.60) | FOLH1RIMKLANAALAD2CPB2GNPAT | |
| SCHEMBL2450650 | 0.86 | FOLH1 (1.00) | FOLH1RIMKLANAALAD2 | |
| SCHEMBL2450656 | 0.86 | FOLH1 (1.00) | FOLH1RIMKLANAALAD2 | |
| SCHEMBL4669761 | 0.86 | FOLH1 (1.00) | FOLH1RIMKLANAALAD2 | |
| SCHEMBL23839908 | 0.86 | FOLH1 (0.87) | FOLH1RIMKLANAALAD2CPB2GNPAT | |
| SCHEMBL15739333 | 0.86 | FOLH1 (1.00) | FOLH1RIMKLANAALAD2 | |
| SCHEMBL15739351 | 0.86 | FOLH1 (1.00) | FOLH1RIMKLANAALAD2 | |
| SCHEMBL15739372 | 0.86 | FOLH1 (1.00) | FOLH1RIMKLANAALAD2 | |
| SCHEMBL1741931 | 0.86 | FOLH1 (1.00) | FOLH1RIMKLANAALAD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11167050-B2 | Metal complex forming compound, metal complex compound formed thereof, radioactive drug containing the metal complex compound, and method of using and preparing the metal complex compound | NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY (JP) | 2021-11-09 | — | — | US | disclosed |
| US-10960089-B2 | Radiolabeled drug | NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY (JP) | 2021-03-30 | — | — | US | disclosed |
| US-20200268913-A1 | RADIOACTIVE DRUG | NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY (JP) | 2020-08-27 | — | — | US | disclosed |
| US-20190091353-A1 | RADIOLABELED DRUG | NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY (JP) | 2019-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11167050-B2 | Metal complex forming compound, metal complex compound formed thereof, radioactive drug containing the metal complex compound, and method of using and preparing the metal complex compound | SLC30A6, AP1M1, SLC39A11 | FOLH1 348/4885RIMKLA 1329/4885NAALAD2 3196/4885 |
| US-20190091353-A1 | RADIOLABELED DRUG | SLC10A1, SLCO2A1, SLC30A5 | FOLH1 125/4885RIMKLA 3890/4885NAALAD2 2393/4885 |
| US-20200268913-A1 | RADIOACTIVE DRUG | TFRC, LUC7L2, MRPL19 | FOLH1 48/4885RIMKLA 1693/4885NAALAD2 1462/4885 |
| US-10960089-B2 | Radiolabeled drug | TFRC, CLINT1, SLC10A1 | FOLH1 168/4885RIMKLA 1904/4885NAALAD2 1735/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.